Crossmark

Effectiveness of trastuzumab deruxtecan rechallenge in a patient with HER2-positive metastatic breast cancer: a case report

Published Online: 2024-09-10

Authors

Tanaka, Yuko https://orcid.org/0000-0002-8563-2554
Ikeda, Naoya

Niho, Seiji

Ishida, Kazuyuki
License Information

Text and Data Mining valid from 2024-09-10

Version of Record valid from 2024-09-10
More Information

Article History

Received: 26 March 2024

Accepted: 1 September 2024

First Online: 10 September 2024

Declarations

:

: The author fully declares any financial or other potential conflict of interest.

: Written patient’s informed consent was obtained for publication of this report.

Document is current